Watch a 25-minute webinar presented by Dr. Resmi Ravindran, a senior scientist at the Clinical Proteomics Core Lab, University of California Davis Medical Center. Learn about the evaluation of a bead-based multiplex SARS-CoV-2 variant neutralization antibody assay for vaccine research. Gain insights into cutting-edge techniques for assessing vaccine efficacy against different coronavirus variants. Explore the potential applications of this assay in ongoing vaccine development efforts and public health strategies.
Evaluation of a Bead-Based Multiplex SARS-CoV-2 Variant Neutralization Antibody Assay for Vaccine Efficacy Assessment
Overview
Syllabus
Evaluation of a Bead Based Multiplex SARS CoV 2 Variant Neutralization Antibody Assay for Vaccine...
Taught by
Labroots
Related Courses
-
Detection of SARS-CoV-2 Neutralizing Antibodies with GenScript's Surrogate Virus Neutralization Test
-
Variant-Resistant Antibody Recognition from a Global Consortium
-
A Saliva-Based RT-PCR SARS-CoV-2 Detection Assay - Development and Deployment
-
Hybrid Capture SARS-CoV-2 NGS Assay and COVID-Dx: A Robust End-to-End Solution for Viral Detection and Surveillance
